1996
DOI: 10.1007/bf00171055
|View full text |Cite
|
Sign up to set email alerts
|

Presynaptic ?2-autoreceptors in mouse heart atria: evidence for the ?2D subtype

Abstract: Presynaptic alpha 2-autoreceptors in mouse atria were characterized in terms of the alpha 2A, alpha 2B, alpha 2C and alpha 2D subtypes. Segments of the atria were preincubated with 3H-noradrenaline and then superfused and stimulated electrically. The affinity of up to 16 antagonists for the autoreceptors was assessed as (1) pEC30% values. i.e. concentrations that increased previously autoinhibited release of 3H-noradrenaline (120 pulses, 3 Hz) by 30%, and (2) pKd values against the release-inhibiting effect of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
24
0

Year Published

1997
1997
2005
2005

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 32 publications
3
24
0
Order By: Relevance
“…In control experiments without carbachol the overflow peaks were similar from S 1 to S 6 , giving S n /S 1 ratios close to unity (data not shown; compare Wahl et al, 1996;Trendelenburg et al, 1999;2003a). The antagonists pirenzepine and methoctramine, when present throughout superfusion, did not change the stimulationevoked overflow of tritium (S 1 ; M 3 -knockout vas deferens).…”
Section: Resultsmentioning
confidence: 75%
See 1 more Smart Citation
“…In control experiments without carbachol the overflow peaks were similar from S 1 to S 6 , giving S n /S 1 ratios close to unity (data not shown; compare Wahl et al, 1996;Trendelenburg et al, 1999;2003a). The antagonists pirenzepine and methoctramine, when present throughout superfusion, did not change the stimulationevoked overflow of tritium (S 1 ; M 3 -knockout vas deferens).…”
Section: Resultsmentioning
confidence: 75%
“…Presynaptic muscarinic receptors in the mouse NMRI, M 2 -knockout, M 4 -knockout and their corresponding wild-type control mice (data not shown; Wahl et al, 1996;Trendelenburg et al, 1999;2003a). In control experiments without carbachol the overflow peaks were similar from S 1 to S 6 , giving S n /S 1 ratios close to unity (data not shown; compare Wahl et al, 1996;Trendelenburg et al, 1999;2003a).…”
Section: Resultsmentioning
confidence: 90%
“…There is now much evidence to support the suggestion (Trendelenburg et al 1993) that presynaptic a 2 -autoreceptors, the prototype a 2 -adrenoceptors (Langer 1974;Starke 1977), belong to the a 2A/D branch of the a 2 -adrenoceptor tree (recent studies: Limberger et al 1995a;Starke et al 1995;Trendelenburg et al 1996a;Wahl et al 1996). An apparent exception are the a 2 -autoreceptors in the human kidney and in human atria which were classified as a 2C Rump et al 1995), in contrast to the autoreceptors in the human saphenous vein (Molderings and Göthert 1995) and probably brain cortex (Raiteri et al 1992; see Introduction of Limberger et al 1995a) which obey the rule and are a 2A .…”
mentioning
confidence: 96%
“…The genetic a 2A/D subtype represents orthologous receptors, derived from a common ancestor gene, but with sufficient inter-species differences in drug affinities to yield the two pharmacological subtypes a 2A and a 2D . The a 2A/D subtype with a 2A pharmacology occurs in humans, rabbits and pigs, whereas the subtype with a 2D pharmacology occurs in rats, mice, guinea pigs and cows (see Bylund et al 1994;Trendelenburg et al 1996 a).…”
mentioning
confidence: 99%
“…However, pharmacological di erences have been revealed either by determining the rank order of potency of an extensive range of antagonists, followed by comparison with known preparations based on correlation coe cient (Renouard et al, 1994;O'Rourke et al, 1994;Trendelenburg et al, 1995), or establishing the potency ratio for pairs of antagonists (Molderings & GoÈ hert, 1995;Trendelenburg et al, 1996a). For example, phentolamine has been shown to be approximately 5 fold more potent than rauwolscine at a 2D -adrenoceptors (Funk et al, 1995;Trendelenburg et al, 1996b;Wahl et al, 1996), while the reverse is true at a 2A -adrenoceptors (Trendelenburg et al, 1994;Molderings & GoÈ hert, 1995). To date, however, there have been no studies concerning the comparative e ect of putative agonists at a 2A -and a 2D -adrenoceptors.…”
mentioning
confidence: 99%